Gilead Sciences, Inc.

Gilead Sciences, Inc.verified

GILD

Price:

$69.96

Market Cap:

$87.16B

Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, an injection for intravenous use, for the treatment of coronavirus disease 2019; and Epclusa, Harvoni, Vosevi, Vemlidy, and Viread for the treatment of liver diseases. It also offers Yescarta, Tecartus, Trodelvy, and Zydelig products for the treatment of hematology, oncology, and cell therapy patients. In addition, the company provides Letairis, an ora...[Read more]

Industry

Drug Manufacturers - General

IPO Date

1992-01-22

Stock Exchange

NASDAQ

Ticker

GILD

The Enterprise Value as of July 2024 (TTM) for Gilead Sciences, Inc. (GILD) is 107.64B

According to Gilead Sciences, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 107.64B. This represents a change of -6.86% compared to the average of 115.56B of the last 4 quarters.

Gilead Sciences, Inc. (GILD) Historical Enterprise Value (quarterly & annually)

How has GILD Enterprise Value performed in the past?

The mean historical Enterprise Value of Gilead Sciences, Inc. over the last ten years is 114.71B. The current 107.64B Enterprise Value has changed 9.28% with respect to the historical average. Over the past ten years (40 quarters), GILD's Enterprise Value was at its highest in in the June 2015 quarter at 164.93B. The Enterprise Value was at its lowest in in the December 2018 quarter at 90.07B.

Quarterly (TTM)
Annual

Average

114.71B

Median

116.80B

Minimum

90.57B

Maximum

135.29B

Gilead Sciences, Inc. (GILD) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Gilead Sciences, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 18.36%

Maximum Annual Enterprise Value = 135.29B

Minimum Annual Increase = -24.26%

Minimum Annual Enterprise Value = 90.57B

Quarterly (TTM)
Annual
YearEnterprise ValueChange
2023120.00B-5.92%
2022127.56B13.33%
2021112.56B14.11%
202098.64B3.30%
201995.49B5.43%
201890.57B-24.26%
2017119.59B4.90%
2016114.00B-15.74%
2015135.29B1.38%
2014133.45B18.36%

Gilead Sciences, Inc. (GILD) Average Enterprise Value

How has GILD Enterprise Value performed in the past?

The current Enterprise Value of Gilead Sciences, Inc. (GILD) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

3-year avg

120.04B

5-year avg

110.85B

10-year avg

114.71B

Gilead Sciences, Inc. (GILD) Enterprise Value vs. Peers

How is GILD’s Enterprise Value compared to its peers?

Gilead Sciences, Inc.’s Enterprise Value is less than Amgen Inc. (231.78B), less than Merck & Co., Inc. (352.14B), less than AbbVie Inc. (356.63B), less than Johnson & Johnson (368.87B), less than Bristol-Myers Squibb Company (130.10B), less than Pfizer Inc. (232.70B), less than Eli Lilly and Company (925.12B), less than AstraZeneca PLC (272.40B),

CompanyEnterprise ValueMarket cap
231.78B$177.47B
352.14B$323.59B
356.63B$300.69B
368.87B$360.71B
130.10B$82.02B
232.70B$163.88B
925.12B$901.36B
272.40B$245.69B

Build a custom stock screener for Gilead Sciences, Inc. (GILD) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Gilead Sciences, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Gilead Sciences, Inc. (GILD) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Gilead Sciences, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the Enterprise Value?

How can you use the Enterprise Value?

What is Gilead Sciences, Inc.'s Enterprise Value?

What is the highest Enterprise Value for Gilead Sciences, Inc. (GILD)?

What is the 3-year average Enterprise Value for Gilead Sciences, Inc. (GILD)?

What is the 5-year average Enterprise Value for Gilead Sciences, Inc. (GILD)?

How does the current Enterprise Value for Gilead Sciences, Inc. (GILD) compare to its historical average?